Tag: therapeutics,
Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing their discoveries, on Thursday said its scientific co-founder Jonathan Kurtis […]
The post Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics first appeared on AlphaStreet.
Bone cancer drug developer OS Therapeutics files for $10M IPO
Pasithea Therapeutics files for $15M mixed shelf offering
Checkpoint Therapeutics files for $150M mixed shelf offering
Cara Therapeutics Inc (CARA) Q4 2022 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q4 2022 Earnings Call dated Mar. 06, 2023. Corporate Participants: Chris Posner — President and Chief Executive Officer Ryan Maynard — Chief Financial Officer Joana Goncalves — Chief Medical Officer Analysts: Sumant […]
The post Cara Therapeutics Inc (CARA) Q4 2022 Earnings Call Transcript first appeared on AlphaStreet.